Loading
Latest filing published 03 Feb 2020 for Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.).
No signal scores available.
This profile gathers the share dealings of Mary Shoemaker in Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.). We count 2 filings; the first trade dates from 16 October 2018 and the latest from 19 December 2019.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 3 February 2020, the filings show a transaction in Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.). Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations